Aehr Test Systems
AEHR Nasdaq Instruments For Meas & Testing Of Electricity & Elec Signals Financials FY2017βFY2026
What Aehr Test Systems does
No business description yet.
- Legal name
- AEHR TEST SYSTEMS
- Fiscal year ends
- May 29, 2026
- Latest annual report
- 10-K Β· Jul 27, 2026
- Accession Β· CIK
- 0001654954-26-006919
0001040470
Revenue and margins
Aehr Test Systems had $50.0M of revenue in fiscal 2026, down 15.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$5.4M in fiscal 2026, β10.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Aehr Test Systems returned β to shareholders in fiscal 2026. The diluted share count rose 3.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Aehr Test Systems can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $31.5M | $47.9M | $49.2M | $24.5M | $116M |
| Debt incl. finance leases | $0.0M | β | β | β | β |
| Net debt / EBITDA | β3.9x | β | β | β | β |
| Debt / equity | 0.0x | β | β | β | β |
| Current ratio | 5.4x | 5.5x | 9.3x | 5.7x | 10.3x |
| Quick ratio | 4.1x | 4.0x | 5.7x | 3.0x | 8.0x |
| Total assets | $62.3M | $98.1M | $128M | $149M | $247M |
| Total liabilities | $11.3M | $22.5M | $16.3M | $25.6M | $27.2M |
| Shareholders' equity | $51.0M | $75.6M | $112M | $123M | $220M |
| Net debt (β = net cash) | β$31.5M | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 3 / 9 | 5 / 9 | 2 / 9 | 7 / 9 | 4 / 8 | 4 / 8 | 1 / 8 | 2 / 8 |
| Accruals ratio | β3.7% | 6.1% | 1.5% | β3.7% | 3.2% | 18.9% | 5.7% | 27.8% | 2.5% | β1.9% |
| Altman Z'' | β2.30 | β1.16 | β5.27 | β6.01 | β8.54 | 7.22 | 7.56 | 11.70 | 7.50 | 12.12 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $18.9M | $29.6M | $21.1M | $22.3M | $16.6M | $50.8M | $65.0M | $66.2M | $59.0M | $50.0M |
| Net interest income | β | β$0.4M | β$0.3M | $0.0M | β$0.0M | $0.0M | $1.2M | $2.4M | $1.4M | $1.4M |
| Gross profit | $6.8M | $12.4M | $7.6M | $8.4M | $6.0M | $23.7M | $32.7M | $32.5M | $23.9M | $17.7M |
| Research and development | $4.7M | $4.2M | $4.2M | $3.4M | $3.7M | $5.8M | $7.1M | $8.7M | $10.5M | $12.6M |
| Operating income | β$4.9M | $0.9M | β$5.0M | β$2.8M | β$4.2M | $7.8M | $13.4M | $10.1M | β$5.7M | β$14.1M |
| Interest expense | $0.7M | $0.4M | $0.3M | β | β | β | β | β | β | β |
| Pretax income | β$5.6M | $0.5M | β$5.2M | β$2.8M | β$2.2M | $9.5M | $14.6M | $12.5M | β$4.3M | β$11.7M |
| Income tax | $0.0M | β$0.1M | $0.0M | β$0.0M | β$0.2M | $0.1M | $0.1M | β$20.7M | β$0.4M | β$4.6M |
| Net income | β$5.7M | $0.5M | β$5.2M | β$2.8M | β$2.0M | $9.5M | $14.6M | $33.2M | β$3.9M | β$7.1M |
| Diluted EPS | β$0.35 | $0.02 | β$0.23 | β$0.12 | β$0.09 | $0.34 | $0.50 | $1.12 | β$0.13 | β$0.23 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | β$4.5M | β$1.4M | β$5.6M | β$2.0M | β$2.7M | $1.5M | $10.0M | $1.8M | β$7.4M | β$3.3M |
| Capital expenditure | $0.5M | $0.6M | $0.2M | $0.2M | $0.2M | $0.4M | $1.4M | $0.7M | $5.0M | $2.1M |
| Free cash flow | β$5.0M | β$1.9M | β$5.8M | β$2.2M | β$2.9M | $1.1M | $8.6M | $1.0M | β$12.4M | β$5.4M |
| Depreciation and amortization | $0.3M | $0.4M | $0.4M | $0.4M | $0.3M | $0.4M | $0.5M | $0.7M | $2.3M | $2.8M |
| Stock-based compensation | $1.0M | $1.0M | $0.9M | $0.9M | $1.1M | $3.0M | $2.7M | $2.5M | $5.2M | $6.8M |
| Acquisitions | β | β | β | β | β | β | $0.0M | $0.0M | $11.1M | $1.8M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $17.8M | $16.8M | $5.4M | $5.4M | $4.6M | $31.5M | $47.9M | $49.2M | $24.5M | $116M |
| Total debt | $6.1M | $0.0M | $0.0M | $1.7M | $1.7M | $0.0M | β | β | β | β |
| Current assets | $29.4M | $29.5M | $20.0M | $17.7M | $19.2M | $60.0M | $89.0M | $97.8M | $88.8M | $184M |
| Current liabilities | $7.9M | $11.1M | $5.5M | $3.9M | $9.1M | $11.0M | $16.3M | $10.5M | $15.6M | $17.9M |
| Inventory | $6.6M | $9.0M | $9.1M | $8.0M | $8.8M | $15.1M | $23.9M | $37.5M | $42.0M | $41.4M |
| Property and equipment, net | $1.4M | $1.2M | $1.0M | $0.7M | $0.7M | $1.2M | $2.8M | $3.3M | $9.0M | $8.9M |
| Goodwill | β | β | β | β | β | β | β | $0.0M | $10.7M | $10.7M |
| Intangible assets | β | β | β | β | β | β | β | $0.0M | $10.8M | $9.6M |
| Total assets | $30.9M | $31.0M | $21.3M | $20.6M | $21.7M | $62.3M | $98.1M | $128M | $149M | $247M |
| Total liabilities | $14.1M | $11.7M | $5.9M | $6.5M | $10.2M | $11.3M | $22.5M | $16.3M | $25.6M | $27.2M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $16.8M | $19.3M | $15.5M | $14.1M | $11.4M | $51.0M | $75.6M | $112M | $123M | $220M |
| Margins | ||||||||||
| Gross margin | 35.9% | 41.9% | 36.1% | 37.6% | 36.3% | 46.6% | 50.4% | 49.1% | 40.6% | 35.3% |
| Operating margin | β26.1% | 3.1% | β23.7% | β12.4% | β25.2% | 15.3% | 20.6% | 15.2% | β9.6% | β28.3% |
| EBITDA margin | β24.6% | 4.5% | β21.7% | β10.7% | β23.2% | 16.0% | 21.3% | 16.2% | β5.7% | β22.7% |
| Net margin | β29.9% | 1.8% | β24.9% | β12.6% | β12.2% | 18.6% | 22.4% | 50.1% | β6.6% | β14.3% |
| FCF margin | β26.3% | β6.5% | β27.6% | β9.8% | β17.6% | 2.1% | 13.3% | 1.5% | β21.0% | β10.8% |
| Net interest share of revenue | β | β1.4% | β1.2% | 0.0% | β0.3% | 0.0% | 1.9% | 3.6% | 2.4% | 2.7% |
| Returns | ||||||||||
| Return on capital | β76.1% | 37.2% | β39.3% | β21.2% | β38.7% | 39.6% | β | β | β | β |
| Return on capital employed | β21.4% | 4.6% | β31.7% | β16.5% | β33.2% | 15.2% | 16.3% | 8.6% | β4.3% | β6.2% |
| Return on equity | β33.6% | 2.9% | β30.1% | β19.0% | β15.9% | 30.3% | 23.0% | 35.4% | β3.3% | β4.2% |
| Return on assets | β18.3% | 1.7% | β20.0% | β13.4% | β9.6% | 22.5% | 18.1% | 29.3% | β2.8% | β3.6% |
| Return on tangible equity | β33.6% | 2.7% | β33.8% | β19.9% | β17.7% | 18.5% | 19.3% | 29.7% | β3.9% | β3.6% |
| Growth | ||||||||||
| Revenue growth | β | 56.4% | β28.8% | 5.9% | β25.5% | 206.2% | 27.8% | 1.9% | β10.9% | β15.2% |
| Net income growth | β | β | β1,091.5% | β | β | β | 54.0% | 127.8% | β111.8% | β |
| EPS growth | β | β | β1,250.0% | β | β | β | 47.1% | 124.0% | β111.6% | β |
| FCF growth | β | β | β | β | β | β | 692.0% | β88.4% | β1,330.6% | β |
| Share count change | β | 39.9% | β1.8% | 102,051.8% | 2.5% | 18.4% | 5.2% | 1.4% | β0.1% | 3.7% |
| Financial health | ||||||||||
| Net debt / EBITDA | β | β12.6x | β | β | β | β3.9x | β | β | β | β |
| Debt / equity | 0.4x | 0.0x | 0.0x | 0.1x | 0.1x | 0.0x | β | β | β | β |
| Interest coverage | β7.3x | 2.3x | β19.8x | β | β | β | β | β | β | β |
| Current ratio | 3.7x | 2.6x | 3.6x | 4.6x | 2.1x | 5.4x | 5.5x | 9.3x | 5.7x | 10.3x |
| Quick ratio | 2.9x | 1.8x | 2.0x | 2.5x | 1.1x | 4.1x | 4.0x | 5.7x | 3.0x | 8.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.5% | 1.9% | 0.8% | 0.7% | 1.4% | 0.8% | 2.1% | 1.1% | 8.5% | 4.1% |
| Stock comp / revenue | 5.3% | 3.4% | 4.3% | 4.1% | 6.6% | 5.9% | 4.2% | 3.8% | 8.8% | 13.5% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 3.0 | 5.0 | 2.0 | 7.0 | 4.0 | 4.0 | 1.0 | 2.0 |
| Altman Z'' | β2.3 | β1.2 | β5.3 | β6.0 | β8.5 | 7.2 | 7.6 | 11.7 | 7.5 | 12.1 |
| Accruals ratio | β3.7% | 6.1% | 1.5% | β3.7% | 3.2% | 18.9% | 5.7% | 27.8% | 2.5% | β1.9% |
Source: SEC EDGAR XBRL filings (CIK 0001040470). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.